title: Evaluation of HIV/AIDS clinical care quality: the case of a referral hospital in North West Ethiopia.
abstract: OBJECTIVE
  To assess the quality of clinical care provided to patients with HIV in Felege Hiwot Referral Hospital. APPROACH AND DESIGN: Normative evaluation based on Donabedian's structure-process-outcome model of health care quality. Cross-sectional
  
  
  METHODS
  was employed to gather data in September 2007.
  
  
  METHODS
  Felege Hiwot Referral Hospital is a government hospital in North West Ethiopia. The hospital is providing clinical care for patients infected with HIV free of patient charge since 2005.
  
  
  METHODS
  The evaluation used 10 process and 5 outcome indicators of quality measured by reviewing 351 randomly selected patient records and interview with 368 patients. Resource inventory was conducted to assess the availability of trained staff, laboratory facilities and drugs required for provision of HIV care.
  
  
  RESULTS
  All resources recommended by the national antiretroviral therapy (ART) Implementation Guideline including trained staff, laboratory facilities and drugs were continuously available, except for a shortage of cotrimoxazole. Despite this, important components of care and treatment recommended by national treatment guidelines were not delivered for significant portion of patients. The study showed that only 45.9% of patients eligible for cotrimoxazole prophylactic therapy (CPT) and 76.8% of patients eligible for ART were actually taking CPT and ART, respectively. Compliance with national guidelines to monitor patients was also found to be a major problem.
  
  
  CONCLUSIONS
  Availability of resources alone does not ensure the quality of HIV care and treatment. The study results indicate a need for regular monitoring and improvement of processes and outcomes of care in the Ethiopian Health System.
authors.affiliation: Jimma University, Ethiopia. kibeltal@gmail.com
authors.forename: Yibeltal Kiflie
authors.initials: YK
authors.lastname: Alemayehu
authors.forename: Oluma Yoseph
authors.initials: OY
authors.lastname: Bushen
authors.forename: Ayalew Tegegn
authors.initials: AT
authors.lastname: Muluneh
mesh_terms: D000293:Adolescent; D019380:Anti-HIV Agents / Q000600:supply & distribution / Q000627:therapeutic use*; D019072:Antibiotic Prophylaxis / Q000592:standards; D002648:Child; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D005002:Ethiopia; D005260:Female; D019983:Guideline Adherence / Q000706:statistics & numerical data; D015658:HIV Infections / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D007223:Infant; D008297:Male; D010043:Outcome and Process Assessment, Health Care / Q000379:methods*; D017060:Patient Satisfaction; D011787:Quality of Health Care; D018119:Stavudine / Q000600:supply & distribution / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000600:supply & distribution / Q000627:therapeutic use; D055815:Young Adult; D015215:Zidovudine / Q000600:supply & distribution / Q000627:therapeutic use
chemical_list: D019380:Anti-HIV Agents; D015215:Zidovudine; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D018119:Stavudine
references.citation: AIDS. 2002 May 3;16(7):1051-8
references.pmid: 11953472
references.citation: JAMA. 2001 Nov 28;286(20):2560-7
references.pmid: 11722270
references.citation: BMJ. 2007 Nov 24;335(7629):1085
references.pmid: 17967826
references.citation: J Acquir Immune Defic Syndr. 2002 May 1;30(1):105-10
references.pmid: 12048370
references.citation: J Antimicrob Chemother. 2004 Jul;54(1):10-3
references.pmid: 15163656
references.citation: AIDS Res Ther. 2006 Mar 20;3:6
references.pmid: 16549012
references.citation: AIDS. 2001 Jun 15;15(9):1181-3
references.pmid: 11416722
references.citation: JAMA. 2000 Oct 4;284(13):1670-6
references.pmid: 11015797
references.citation: AIDS. 1999 Sep 10;13(13):1687-95
references.pmid: 10509570
references.citation: Ethiop Med J. 2006 Jul;44(3):237-44
references.pmid: 17447389
references.citation: N Engl J Med. 2003 Jun 26;348(26):2635-45
references.pmid: 12826639
references.citation: JAMA. 2001 Nov 28;286(20):2568-77
references.pmid: 11722271
references.citation: Milbank Q. 2005;83(4):691-729
references.pmid: 16279964
references.citation: Clin Infect Dis. 2007 May 15;44(10):1361-7
references.pmid: 17443476
references.citation: AIDS. 2005 Jan 28;19(2):163-8
references.pmid: 15668541
references.citation: AIDS Care. 2005 Jan;17(1):10-22
references.pmid: 15832830
references.citation: Lancet. 1999 May 1;353(9163):1463-8
references.pmid: 10232311
references.citation: AIDS. 2000 Sep 8;14(13):1985-91
references.pmid: 10997404
references.citation: Ann Intern Med. 2000 Jul 4;133(1):21-30
references.pmid: 10877736
references.citation: JAMA. 2000 Apr 5;283(13):1715-22
references.pmid: 10755498
references.citation: Milbank Q. 2005;83(4):843-95
references.pmid: 16279970
references.citation: Ann Intern Med. 2003 Apr 15;138(8):620-6
references.pmid: 12693883